Company Accounts and Tax Online 12011916 Board of Directors 1.6.24 31.5.25 31.5.25 No description of principal activity true 12011916 uk-bus:EntityHasNeverTraded 2024-06-01 2025-05-31 iso4217:GBP xbrli:pure 12011916 2023-06-01 2024-05-31 12011916 2025-05-31 12011916 2024-06-01 2025-05-31 12011916 2024-05-31 12011916 countries:EnglandWales 2024-06-01 2025-05-31 12011916 curr:PoundSterling 2024-06-01 2025-05-31 12011916 uk-bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 12011916 uk-bus:FRS102 2024-06-01 2025-05-31 12011916 uk-bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 12011916 uk-bus:AbridgedAccounts 2024-06-01 2025-05-31 12011916 uk-bus:RegisteredOffice 2024-06-01 2025-05-31 12011916 uk-bus:Director1 2024-06-01 2025-05-31 12011916 uk-bus:Director1 2024-06-01 12011916 uk-bus:Director1 2025-05-31 12011916 core:AfterOneYear 2025-05-31 12011916 core:AfterOneYear 2024-05-31 12011916 core:WithinOneYear 2025-05-31 12011916 core:WithinOneYear 2024-05-31 12011916 core:WithinOneYear 2024-06-01 2025-05-31 12011916 core:AfterOneYear 2025-05-31 12011916 core:AfterOneYear 2024-05-31 12011916 core:AfterOneYear 2024-06-01 2025-05-31 12011916 core:ShareCapital 2025-05-31 12011916 core:ShareCapital 2024-05-31 12011916 core:RevaluationReserve 2025-05-31 12011916 core:RevaluationReserve 2024-05-31 12011916 core:RetainedEarningsAccumulatedLosses 2025-05-31 12011916 core:RetainedEarningsAccumulatedLosses 2024-05-31 12011916 1 2024-06-01 2025-05-31

# SUSSEXMED LTD

## Company Registration Number:
12011916 (England and Wales)

## Unaudited abridged accounts for the year ended 31 May 2025

## (Dormant)

## Period of accounts

## Start date: 01 June 2024

## End date: 31 May 2025

# SUSSEXMED LTD

## Contents of the Financial Statements

for the Period Ended 31 May 2025

Company Information - 3 |
Report of the Directors - 4 |
Profit and Loss Account - 5 |
Balance sheet - 6 |
Additional notes - 8 |
Balance sheet notes - 11 |

# SUSSEXMED LTD

## Company Information

for the Period Ended 31 May 2025

Director: |  | Paul Grant
Registered office: |  | 15 Eatenden Lane Mountfield Robertsbridge England TN32 5LT
Company Registration Number: |  | 12011916 (England and Wales)

# SUSSEXMED LTD

## Directors' Report Period Ended 31 May 2025

The directors present their report with the financial statements of the company for the period ended 31 May 2025

Directors

The directors shown below have held office during the whole of the period from 01 June 2024 to 31 May 2025
Paul Grant

The company was dormant and did not trade in the period.

This report was approved by the board of directors on 15 September 2025
And Signed On Behalf Of The Board By:

Name: Paul Grant
Status: Director

# SUSSEXMED LTD

## Profit and Loss Account

for the Period Ended 31 May 2025

The company was dormant and did not trade in the period. The company received no income and incurred no expenditure in the period and therefore did not make either a profit or loss.

# SUSSEXMED LTD

## Balance sheet

As at 31 May 2025

| Notes | 2025 £ | 2024 £
--- | --- | --- | ---
Fixed assets
Intangible assets: | 4 | 0 | 0
Total fixed assets: |  | 0 | 0
Current assets
Stocks: |  | 1 | 1
Total current assets: |  | 1 | 1
Net current assets (liabilities): |  | 1 | 1
Total assets less current liabilities: |  | 1 | 1
Total net assets (liabilities): |  | 1 | 1

The notes form part of these financial statements

# SUSSEXMED LTD

## Balance sheet continued

As at 31 May 2025

| Notes | 2025 £ | 2024 £
--- | --- | --- | ---
Capital and reserves
Called up share capital: |  | 1 | 1
Shareholders funds: |  | 1 | 1

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 31 May 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 15 September 2025
And Signed On Behalf Of The Board By:

Name: Paul Grant
Status: Director

The notes form part of these financial statements

# SUSSEXMED LTD

## Notes to the Financial Statements

for the Period Ended 31 May 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# SUSSEXMED LTD

## Notes to the Financial Statements

for the Period Ended 31 May 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 0 | 0

# SUSSEXMED LTD

## Notes to the Financial Statements

for the Period Ended 31 May 2025

- ## 3. Off balance sheet disclosure

  No

# SUSSEXMED LTD

## Notes to the Financial Statements

for the Period Ended 31 May 2025

- ## 4. Intangible assets

  | Total
  --- | ---
  Cost | £
  At 01 June 2024 | -
  Additions | -
  Disposals | -
  Revaluations | -
  Transfers | -
  At 31 May 2025 | -
  Amortisation |
  Charge for year | -
  On disposals | -
  Other adjustments | -
  Amortisation at 31 May 2025 | -
  Net book value |
  Net book value at 31 May 2025 | -
  Net book value at 31 May 2024 | -

  No assets